A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alzheimer's Disease Alzheimer Disease Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis (ALS) Autoimmune Diseases Autoimmune Diseases of the Nervous System Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Chorea Cognition Disorders Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dementia Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Dyskinesias Genetic Diseases, Inborn Heredodegenerative Disorders, Nervous System Huntington Disease Huntington's Disease Immune System Diseases Mental Disorders Metabolic Diseases Motor Neuron Disease Movement Disorders Multiple Sclerosis Nervous System Diseases Neurocognitive Disorders Neurodegenerative Diseases Neuromuscular Diseases Nutritional and Metabolic Diseases Parkinson Disease Parkinson's Disease Parkinsonian Disorders Proteostasis Deficiencies Spinal Cord Diseases Synucleinopathies TDP-43 Proteinopathies Tauopathies

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sanguine Biosciences

Sherman Oaks, California, 91403, United States

About this study

Blood samples are collected in the comfort and safety of your home by a certified medical professional. We have mobile phlebotomists located in major metropolitan areas around the nation for your convenience.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Males and females >18 to 100 years old
A diagnosis of neurological condition
Proof of diagnosis can be provided

Control group: Healthy donors, males and females, 18 to 100 years of age

Exclusion criteria

Receipt of blood products within 30 days of study enrollment
Receipt of an investigational (unapproved) drug within 30 days of study enrollment

Treatment and study plan

Primary outcomes

Biospecimens & Clinical Data collection from patients with neurological diseases.

Time frame: 2 years

The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.

Sponsors and collaborators

Lead sponsor

Sanguine Biosciences

Industry

Registry information

Official study title

A Multi-Center Longitudinal Biorepository Study to Provide Biospecimens & Clinical Data From Neurological Disease Patients To Approved Pre-Clinical And Clinical Investigators for Drug & Biomarker Studies

Important dates

Study start: 2011
Primary completion: 2015
Study completion: 2015
First posted: May 7, 2012
Registry last updated: Nov 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed